SoftBank-backed Neumora Therapeutics aims to raise up to $265m in US IPO

Biopharmaceutical firm Neumora Therapeutics, backed by Amgen and Japan's SoftBank, is aiming to raise up to $264.8 million in its US IPO.

Related Keywords

Russia ,Ukraine ,United States ,America , ,Amgen ,Softbank ,Neumora Therapeutics ,Massachusetts Based Neumora ,